Good morning, everyone and welcome to the Darling Ingredients Inc. Conference Call to discuss the company's Second Quarter 2019 Financial Results. On the call today are Mr. Randall C. Stuewe, Chairman and Chief Executive Officer; Mr. Brad Phillips, Executive Vice President and Chief Financial Officer; Mr. John Bullock, Executive Vice President and Chief Strategy Officer; and Ms. Melissa Gaither, Vice President of Investor Relations and Global Communications. After the speakers’ opening remarks, there will be a question-and-answer period and instructions to ask a question will be given at that time. Today's call is being recorded. [Operator Instructions] I would now like to turn the call over to Melissa Gaither, Vice President of Investor Relations and Global Communications for Darling Ingredients. Ms. Gaither, please go ahead.

Thank you, Andrew. Good morning, everyone and thank you for joining us to discuss Darling Ingredients' earning results for the second quarter ended June 29, 2019. To augment management's formal presentation, please refer to the presentation section of our IR website for the earnings slide deck. Randy Stuewe, our Chairman and CEO, will begin today's call with an overview of our second quarter operational and financial results, focusing on year-over-year comparisons, followed by a discussion about some of the trends impacting our business. Brad Phillips, Executive Vice President and Chief Financial Officer, will then provide additional details about our financial results. Finally, Randy will conclude the prepared portion of the call with some general remarks after which we'll be happy to answer your questions. Please see the full disclosures of our non-U.S. GAAP measures in both our earnings release and earnings slide presentation. Now for the Safe Harbor statement, this conference call will contain forward-looking statements regarding Darling Ingredients business opportunities and anticipated results of operations. Please bear in mind that forward-looking information is subject to many risks and uncertainties, and actual results may differ materially from what is projected. Many of these risks and uncertainties are described in Darling's Annual Report on the Form 10-K for the year-ended December 30, 2018, our recent press release announced yesterday, and our filings with the SEC. Forward-looking statements in this conference are based on our current expectations and beliefs, and we do not take any duty to update these forward-looking statements made in this conference call or otherwise. Now I'll turn the call over to Randy.

Thanks, Melissa. Good morning everyone. Thanks for joining us. Second quarter results reflect our diverse global platform and our integrated supply chain resulting in overall improved earnings in a difficult macro environment. In fact, in our earnings release issued yesterday, we highlighted Diamond Green Diesel’s growing earnings contribution and material impact to our business which when combined with our core adjusted EBITDA results yield at a pro-forma EBITDA of $159.4 million. This included $115.5 million from our core business and an impressive $43.9 million from Diamond Green Diesel. Of note, earnings included a gain and $13.2 million from a vacant China property sale and net income for the quarter reflects the absence of $54 million of one-time costs incurred in 2018 second quarter. Brad will give you a little more detail on that in its financial remarks. Now looking at our segment performance, the feed segment faced significantly lower finished protein pricing due to unresolved trade agreements with China and repercussions from the African swine fever epidemic. Overall, we saw protein meal markets substantially lower by 25% to 30% versus last year due to a glut of protein as North American and European markets responded to the extensive hog herd depletion in China. Late in the quarter fat pricing responded positively to higher corn prices in the U.S. and increased energy market demand worldwide. As markets cycled higher, our North American raw material formulas lag, but we expect forward supply chain pricing to DGD will react positively in the third and fourth quarters. Global raw material volumes remain high and we're up 1.6% year-over-year in the segment. In the food segment, our global collagen business delivered greatly improved margins versus last year benefiting from higher global demand especially for Peptan, our premium collagen product. That business line continues to identify…

Thanks, Randy. Net income for the second quarter of 2019 totaled $26.3 million or $0.16 per diluted share compared to a net loss of $30.4 million or net loss of $0.18 per diluted share for the 2018 second quarter. The net loss for the 2018 second quarter include cost of $23.5 million related to debt extinguishment for our euro bond refinancing compared to $12.1 million of debt extinguishment cost reported in the second quarter of 2019 related to the U.S. bond refinancing. In the 2018 second quarter, we also reported a $15.5 million loss from the sale of our Terra Renewal Services subsidiary and $15 million of restructuring costs related to the closure of the Argentina gelatin plan. SG&A for the quarter was $81 million in line with the guidance provided last quarter and lower sequentially due to a larger portion of annual compensation expenses being recorded in Q1, which occurs each year. We continue to anticipate a quarterly SG&A run rate of approximately $80 million per quarter for the remainder of the year. Interest expense was $20.8 million for the period compared to $23 million in the second quarter of 2018. The decrease was primarily due to refinancing the 515 million Euro senior notes from four and three quarters percent to three and five eights percent in the second quarter of fiscal 2018. Now looking at taxes, the company reported income tax expense of $7.8 million for the three months ended June 29, 2018. The effective tax rate was 20% which differ slightly from the federal statutory rate of 21% due primarily to the relative mix of earnings among jurisdictions with different tax rates and discrete items including the recognition of the deferred taxed asset for which no tax benefit had previously been recorded. The company also paid $9.7 million of income taxes in the second quarter. As Randy mentioned, Congress continues to discuss tax extinguish package including the bio-fuel tax credit. We are hopeful that the bio-fuel tax incentives which has bipartisan support will ultimately be re-enacted during the year. For 2019, we are projecting an effective tax rate of 30% excluding the bio-fuel tax credit. If the tax incident is reenacted retroactively for 2018 and for 2019, the effective tax rate is projected to be 15%. Finally, we are projecting cash taxes of approximately $25 million for the remainder of fiscal 2019. As previously mentioned, we refinanced the 500 billion U.S. notes to a 5 and 5.25 rate and extended the maturity to 2027. Capital expenditure of $167.9 million were made during the first six months of fiscal 2019, against a projected $300 million for the full fiscal 2019. We paid down $18 million in debt during the quarter and our liquidity remains strong with unrestricted cash of $87.1 million and $913 million available under our revolving credit facility. Also as mentioned, subsequent to quarter end, we received a 37.8 million dividend from Diamond Green Diesel. With that I'll turn it back over to you, Randy.

Thanks Brad. Overall, I'm very pleased with the agility of our teams and responding to and successfully overcoming the headwinds in the current challenging macro environment. We capitalized on the diversity of our business, continued to identify new opportunities to maximize the performance of our assets and leveraged our global platform and integrated business structure to deliver a track record of sustainable performance and shareholder value. We expect to see an improved second half of the year in our core business segments and a full year performance by DGD of a $1.25 EBITDA per gallon. We expect raw material volumes to remain strong in North America with some leakage from Europe to China. Fat prices should further improve while protein over supply will continue to pressure prices as we manage through trade uncertainty and the ASF outbreak in China. Our global collagen business is making raw material pricing adjustments to further strengthen margins and we expect market share gains as our Peptan product line expands to address global demand. We continue to make meaningful progress towards our long term strategic objectives which includes maximizing returns from DGD and executing on our existing and announced growth channel investments. The cornerstone of Darling’s success is rooted in our entrepreneurial culture and the commitments of our entire team to leave positive impact on your environment and drive sustainable solutions for feeding and fueling a growing world. With that Andrew let's go ahead and open it up to Q&A.

We will now begin the question-and-answer session. [Operator Instructions] The first question comes from Adam Samuelson of Goldman Sachs. Please go ahead.

Yes, thanks, good morning everyone.

Good morning Adam.

So Randy, I am hoping to maybe a little bit elaborate more on your comments about improved second half in the base business and talk a little bit about some of maybe the divergent dynamics in the fat side versus proteins, kind of how maybe contract lags, kind of pull some earnings out of the second quarter. And kind of the volatility you are seeing in crop prices especially on the corn side, corn to the upside, soy to the down and how that kind of influences the realization in the back half?

I will give a little bit color on that. I mean obviously, we will break it into both the core business by segment here. I mean, the feed segment sequentially was pretty much flat quarter-over-quarter while prices moved down on the protein side anywhere from 10% to 15% in that business. And so, as you have the raw materials supply agreements, we were chasing markets if you will, in a sense where what you buy today is sell for less tomorrow until you find bottom there. So obviously, at the end of the day, the protein side both in Canada, the U.S. and even Europe, we were unable to make raw material adjustments or lowering what we pay for raw material to offset those falling markets. Conversely, we saw fat prices start to improve but it really didn't happen until the end of June or mid-June and you always have to remember that Diamond Green Diesel for our North American assets has a supply chain that’s somewhere between 60 and 75 days out. So basically, we were forward sold in an improving market. So the comments about an improving second half is, we believe that we'll see back prices improve for two reasons one, at the end of the day continued strong demand from the global bio-fuel markets in Diamond Green Diesel plus we've seen an improvement in the price of corn especially cash corn and so we're seeing strong feed demand from the use of fat. And if you look at feed demand in North America or animal production there's no sign of any slowing yet of the poultry markets, the beef and the pork side. They're feeding a lot of wheat and when they feed a lot of wheat they need a lot of fat. So we'll continue…

A lot of helpful color and then just to follow up on Diamond Green and the renewable diesel margins, how does the blenders tax credit impact both the LCFS and the [RENT] markets if at all as we think about the margins kind of from let's say 4Q onwards, if Congress actually does get the BTC passed?

Yes. This is John Bullock. I mean, at the end of the day obviously the extra dollar helps with the margins. If the dollar tax credit is in effect, then in theory the rest of the green premiums, the LCFS and the [RENT] don't have to do quite as much work to incent the production. However, the LCFS market is very tight obviously with the very aggressive growth plans that there are in California as well as a whole bunch of other places in the world around the LCFS fuels. I'm not so sure that the dollar tax credit being in effect or not being in effect is going to have much impact. That market should remain very, very strong. The [RENT] market will be impacted by whether or not the tax credit is there or not. It'll be a little bit higher, not a tax credit it'll be a little bit lower if there is a tax credit. So at the end of the day there is some relationship not so much with the LCFS. I think that's strong by itself and it really doesn't matter what the government does with the tax credit.

I appreciate the color. I'll pass it on. Thanks.

The next question comes from Heather Jones of Heather Jones Research LLC. Please go ahead.

My first question is on Europe. So two parts, when specifically do you expect the food margins to catch up for the cost pass through on gelatin and two, in the core rendering business given that we're now starting to see moves in fat prices and all. Do you think the move and product pricing will be enough to offset the reduced operating leverage from less raw materials? So those are my two questions on Europe and then I have a follow-up.

Yes. I mean, the collagen business obviously is a multi continent, four continent business. We're having strong results in China. The Peptan business is really anchored out of South America today and then strong results here in North America. Given the pigskin volatility that's happened and the prices have moved up 30%- 40% in Europe that caused some margin compression in the European plants the couple two, three plants that we have over there, we'll see that widen back out. So I mean, if you take and you take out [Indiscernible] property sale out of the Q2, I think we will have a pretty consistent solid run rate in that business for the balance, in the food segment for the balance of the year. I don't anticipate much more tonnage leaking out of, what I call the bone processing business and then the fat melting business right now at this time, I think that it's a pretty well saturated. We've had to make some raw material adjustments. So the food segments I think it is pretty representative of how it's going to move forward here. The feed segment, the challenge that I was alluding back to Adam was that fat prices improved late in the quarter, but there's no way could they overcome the decline in protein. What I'm trying to decode for you now is, it feels like protein has, I always hate to call a bottom, but feels like we're near the bottom there. We are too big of historical discount globally now to soybean meal and that's what's given me the courage to step forward and say that we're flat now. Our formulas and processing agreements have adjusted now and going forward we should be able to widen out those margins going forward. And then, I think that the thing is, this is whatever August 7, August 12, the U.S. government comes out with their crop report and there is a lot of uncertainty out there of what the status is of the corn and soybean crop and I've never seen in my career here the unknown and the uncertainty that we've ever had in how many acres are planted, how many are going to be harvested and what the yields are going to be this year. So I think hang on to the 12th and we could see a surprise that would say that there's a lot less corn out there. I had the honor of traveling yesterday in the Midwest to go look and there's a wide variation, the maturity level of the corn crop out there right now from some that was planted so late with no tasseling to some that looks pretty good. So we'll see where we go there, but I think that at the end of the day will flow through to better fat prices and stable protein prices going forward, Heather.

I guess, I was wanting to talk about Europe specifically because there's a chance that as AFS situation evolves that it's going to translate to increased demand here. So Europe is sort of on the front line. So I just wanted to talk about it specifically like you've got lower raw material volume there which clearly reduces your operating leverage. So do you think that as these higher prices move through the system, do you anticipate the benefit from higher pricing to more than offset reduced operating leverage?

Well, let me correct you on something. The only lower raw material volumes we're seeing are in the food segment and that's such a small portion of the food segment. It's really immaterial. Our cat 1, 2 and 3 processing businesses in Europe are up year-over-year, quarter-over-quarter. So I don't see any type of change there, right at this moment. I think that the view is that the margin structures of animal production in Europe have improved, now whether they actually will produce more animals in response to China's long-term demand we shall see. Environmentalists have a position on that but at the end of the day the markets are encouraging, additional production everywhere in the world to get ready to feed China. It's simple to say, we don't know how much demand is going to come out of China for poultry, pork or even beef here and the one thing for certain right now is, it doesn't appear that it's coming from the U.S. It'll come from China or from Europe first and maybe South America until the trade disputes put to bed. So there isn't any really operating leverage discussion to have on Europe today as it looks very consistent going forward other than a little bit of pressure in the food segment.

Thank you and my follow-up is on China. So you had excellent visibility into what's been going on there as far as losses, the magnitude and just wonder if you could update us on your thinking there like, your blood plasma supplies I mean what is your operations on the ground telling you as far as the magnitude of the issue there?

Still a lot of unknowns, our collagen business there is the food demand side and the nutraceutical and pharmaceutical demand remains strong. We saw pigskin prices run up and then they backed off. We saw hide prices run up and then they leveled off. We were able to adjust margins. So our exposure there is, there's quite a few less pigs available. There can't really put any more detail around it. Our blood business there is right now basically treading water, operating at breakeven as we try, basically we used to sell hemoglobin and plasma. The red cells, the aquaculture and then the white cells to baby pig starter feeds, we are keeping those products if you will commingle today and they're going all the aquaculture and a little bit to pet food 95% aquaculture. We've not seen any real, I would say our supplies of forcing blood are down anywhere from 25% to 50% depending on where you're at in the country today. Clearly, the Chinese government is working diligently to try to build a bio-security plan to isolate the kind of the small producer, on-farm producer. So I think there's no way that they have this situation under control today. And so, time will tell but right now our businesses are pretty steady and safe going forward.

Okay, perfect. Thank you, so much.

The next question comes from Craig Irwin of ROTH Capital Partners. Please go ahead.

Hi, good morning and thanks for taking my questions.

Good morning, Craig.

So Randy, on Diamond Green was having a heck of a quarter; I saw that they the plant operated a 106% utilization. Is there an opportunity for additional debottlenecking there, can we see some capacity creep on the existing footprint without the expansion to Super Diamond?

Yes, this is John Bullock. We just got to the 275 million gallon level late last year. Still kind of learning the new plant or the expanded plant as we're talking about. I think through the first half of the year we're running a 280 million 282 million gallon pace. From time to time, we need to work on the unit. Our guidance still holds at 275 million for this year. As we get into next year, and now is it possible that we could be able to be a bit than 275. Yes, it's possible as we learned the unit, we may be out move it up a little bit but it's too early to make any predictions or calls about that. 275's our guidance and we should be around there.

Great, that's good to hear. My follow-up is about BTC. So, it's good to see you taking a constructive outlook on renewals, I share your view. You've been conservative in the past, so that's a nice change. Can you maybe share with us what the current thinking is for the use of proceeds when we get this cash in the bank? Is this something that Diamond Green will primarily invest in growth CapEx to cover that $1.1 billion CapEx issued for Diamond or is a portion of it likely to be dividend back and used in the core business?

Yes, Craig. And I mean, as you know there is a dividend policy that exists within Diamond Green Diesel and I think we keep a floating 50 million reserved there. So, anything that comes in from that we will look at in dividend back to the parent companies as we go forward. As we said, we expect where the margin structure is and the production rates that John referred to through 2019, '20 and '21 here to support the $1.1 billion of investment in there. So, we'll go ahead and dividend it back and move forward from there. And the only reason you wouldn’t was if margin structures radically changed here which we're not remotely seeing that. In fact, we're seeing margin structures even widen out from the $1.25 a gallon right now. So, we feel pretty optimistic there. As Brad tried to allude and I've tried to say, it's a really a timing thing is we anticipate they're going to and we've optimistic we'll find to be hit with sometime after they reconvene in September. And depending on if it's September or October or November, when it comes through then and you file for the retroactive and the prospective and then it's really when do they mail the check and that could be anywhere from December to Q1 right now. So, it's just really a timing deal for us.

Great. Thanks again for taking my questions.

The next question comes from Ken Zaslow of Bank of Montreal. Please go ahead.

Hey, good morning to everyone.

Good morning, Ken.

Two questions. One is probably an easy one, one's probably a little bit longer term. The first one, if I look at the biodiesel margin -- the bio fuels margins, Diamond Green Diesel significantly outperformed the industry. Can you talk about the recapturing of the LCFS credit, it seems like that was partly the spread relative to the market margins. I'll start there and then I'll have to follow-up.

Yes Ken, this is John Bullock. I think as we've talked about in the past, as the LCFS markets have developed 2.5 years ago we didn’t move anything in the LCFS markets. Now, all of it moves to one LCFS market or another. And because of the demand increases that's occurred in those markets, as time moves along here and we're able to get a little bit more and a little bit more of that LCFS. So, I think as you look at what our earnings have been so far this year, it is fair to say that yes it is because in part we are receiving a greater portion of the LCFS premium.

Can you give more clarity on that, are you getting 80%, 90%, 40%, any sort of range or any sort of parameters would be helpful here.

Yes, I understand that and I think we've been asked that question multiple times. We have not really I believe given any specific guidance around that. Ken, you know part of this is this is a negotiation between us and our customers that are going on out there. Obviously, those contracts and the information contained in those contract is confidential information. We certainly would not be in a lot of position to where we are providing confidential information from a person that we have a critical -- for customers that we have a critical relationship with. All I can tell you is that it has been improving, is improving and looks like it will continue to improve.

Okay. Randy, my second question is when you talk about food and feed from the back half of the year, I understand what you're talking about and I get it. I think a bigger question is how do you feel the building blocks for 2020 and 2021 for those businesses are I'm assuming you don’t expect food to be at this level and perpetuity and I'm assuming feed should have a little bit. But how do you kind of frame them and I'm not looking for exact guidance for 2020, 2021, but I mean that would be a framework from which to help us aware, and that would be great.

Yes, I mean I think looking forward here depending on what happens and specifically in the feed segment, we've seen tonnage continuing to be strong, maybe leveling off here, we've been through five years of growth in the tonnage side of the business in both North America and Europe now. I don’t really see much slowing going on there but maybe a little less rate. We made a lot of investments over the last three to four years in the core rendering business both in the U.S., up in Canada and to a degree in Europe, to capture that volume growth such that within our supply chain we can control more low carbon feedstock around the world to support our expansions and our pending expansions. So, we feel pretty good going forward that the tonnage in the core rendering business is going to continue. We think that we'll be able to widen out margins. We've been starting up a lot of plans around the U.S. over the last 18 months and trying to get an established customer bases and supply bases and widen out margins. So, it was pretty good that there is a pretty aggressive program to widen up those margins. We've seen where we been unable to overcome here in the short term, Ken, and this is what we think will widen out next year is we -- there's a poultry slaughter has been very strong. We captured a lot of that growth in our new plant, and as we start to gain approvals and government approvals into those businesses for cat food allocations, we should be able to get some additional margin there. As I referred to in Q2 here, we saw the pet food margins narrow substantially almost a $100 year-over-year from what they were. Part…

Great, really appreciate it. Thank you.

Yes, you got it, okay.

The next question comes from David Katter of Baird. Please go ahead.

Hi guys, thanks for taking the question.

Sure.

You just touched on it there, I guess two on margins at Diamond Green Diesel. The first is can you kind of the guidance seems to imply a pretty big step-up in margins in the second half. Can you give us a little more details on the drivers there? And then second, can you talk a little bit about the change in your outlook from the Q1 call to now. Is that just where margins came in Q2 or are there change of expectations for the second half of year that changed the outlook to $1.25 from kind of the range we were at before?

Yes, this is John Bullock. I mean, that’s probably more of a distinction without a difference. We talked about a $1.25 to a $1.40 earlier in the year, we just simply said a $1.25 in our most recent. We'll be in the $1.40 range quite frankly, pretty good July. So, at the end of the day, we're not really changing anything from an outlook perspective on Diamond. We just always want to be conservative to and what we're saying about the earnings potential. So, I wouldn’t take any hidden meaning and to the fact that we didn’t say a $1.25 do a $1.40 for the balance of the year. We're feeling good about where we are from a margin perspective at Diamond Green Diesel.

Got it. And then, kind of the step-up to the second half, you said that margins have been good in July and what other visibility do you have there?

I mean, when all were buying our fat, when all were selling our fuel and so, we feel good about where we are from a margin structure, I mean I don’t --. Diamond's been extremely consistent when you take out the hedge impact that we had since the fourth quarter of last year through the second quarter of this year. Dead on at $1.25 a gallon, it continues to run very well in terms of our margin where right on where we think we're going to be and as we capture more and more of the LCFS premium, we can move that up a little bit. Now, that kind of variation quarter-to-quarter a little bit and sometimes I think that there is a lot of bit too much of a focus on quarter-to-quarter. When you go back and look at Diamond on an annual basis, what you see is more gallons and great margins and more money every year and we have no reason to discount that that's kind of not going to be the situation going forward.

Great, thanks very much.

The next question comes from Benjamin Hogan of Inherent Group. Please go ahead.

Hey guys, good morning.

Good morning.

Good morning, Ben.

So, a couple of questions. One, in the past you guys have explained that Darling has fixed our margins on the core rendering business and then a minority portion of your throughput takes on some commodity risk. So, my question is where within rendering might you be feeling the impact of the U.S. China tariffs and the African Swine Fever that you called out the most. Can you give us some examples?

Yes, this is John Bullock. A pretty interesting question. I mean, I think the background of this is African Swine Fever is a very significant of death for the agricultural industry around the world. It is difficult to get to handle one exactly where all of the various threats associated with the run. It's extremely difficult because getting exact information or accurate information on what's actually happening with it out at China is impossible for the world to really know. I think obviously 30% or 50% of the hogs in China are dead. That means that a significant portion of the world animal population is temporarily diseased. And there is going to have to be a reallocation around the world to meet that demand. The demand is still there though, that's the important part about this. We have just a disruption in terms of the number of animals that are currently living on the earth. The demand for the meat that comes from those animals are still there. And that's going to be regenerated from various places; Europe, the U.S., South America. And then, when you overlay the current trade dispute between China and the U.S., that makes the reallocation process even that more difficult to look into. So, expect some kind of disruptions in those types of things as we go to the next six to 18 months. But the fundamental thing that everybody has to remember is the pigs might be dead, the demand for the meat is still there. And it's going to be met by the world market and we are positioned to process the byproducts that come from that meat wherever it happens to be produced.

And Ben, this is Randy. John's comments are spot-on. I mean when you start to think about both intended and unintended consequences, you start in China itself and you've got left animals to feed. So the soybean processing industry there is shutdown, a lot of capacity so therefore they're importing less beans. Cargill there is a press release out, shutdown their feed mills, six feed mills as they couldn't find animals to feed and so then you say well if they're crushing less beans that means they're making less soybean oil. So they're going to have ultimately import probably additional soybean oil or palm oil or canola oil or something to feed the people and then they were a strong importer of a lot of different proteins around the world from DDGs out of the U.S., from canola meal out of Canada, meat and bone meal out of Argentina. They're importing less and all those products are still being processed and they have to find homes around the world within the geography typically that they're produced. So you're getting this dislocation and disruption that we've never seen before. It used to be that you could correlate meat and bone meal or mixed PC meat and bone meals to $50 under soybean meal, the $50 over soybean meal and if it got 50 above, you better sell everything that got 50 below you knew someone was going to buy everything. We went to a 150 a ton underneath soybean meal in the quarter here which was unheard of. So formulas or processing agreements differ all around the world for us and in Europe, we kind of set prices every 60 days with our raw material guys. In Canada every 90 days and anywhere from a week to a month here in the U.S. and so they could just never catch up. You can never renegotiate quick enough with how far proteins, from poultry proteins to mixed PC, the ruminants, the pork proteins fell during the quarter and that's where we're hoping and we're optimistic that they're normalizing here and we saw them normalized quite a bit and the impact of it within the second quarter here at least the start of the third quarter now.

Thanks for all that color and all things considered and rendering business performed quite well I would say and kind of demonstrated its earnings power and stability. One more question for you. On the last call you talk how you are in the final stages of ramping up to report on workplace safety. Can you give us an update on how that's going and maybe an example of what you plan to report?

Yes. And in fact, we obviously, the way we operate is, we had our board meeting here Monday, Tuesday and then obviously the earnings release yesterday and then the earnings call today is a pretty typical for us. Within the board meeting this time, we presented our full CSR, ESG program to the board for approval and it involves basically the same program that we have rolled out verbally and to a degree at the BMO conference this year of safe food, safely clean air, clean water and then improve communities and employee awareness here. And we now turn that into the next level as we've looked at ISS and the [Glass Lewis] programs and the different thing, ratings that are out there and we have created an ESG fact sheet that I'm making eye contact with Melissa here that hopefully we will have out here sometime at the start of Q4, where we will start to show you the last several years basically the analytics that range from greenhouse gas reduction to safety within to water recycling on a global level that fits with SASB and some of the different consultancy and agency groups that have to approve the number. So I would say, Ben hang with me, we hear you loud and clear. We look at the foundation of the program as disclosure, disclosure, disclosure and with that comes a responsibility for accuracy and with 200 and some facilities around five continents, we're making sure all the data is accurate and auditable before we release it here, but it's coming soon.

Thanks guys. Appreciate it.

And we have a follow-up from Heather Jones of Heather Jones Research LLC. Please go ahead.

Thanks for taking the follow-up. I just wanted to go back to food because I remember being very surprised by how well it did in Q1 and I know astound some sequentially, but still up pretty dramatically in Q2. And it's just been a big step change that I wanted to dig in more. One, I was wondering, once you’re able to get pricing adjusted for the higher pigskin cost, etcetera. Do you think it's possible to get back to Q1 levels or are we going to see more in the Q2 range? And then secondly, could you help us understand more like how much of this capacity brought up and how much is left to come in 2020?

Yes. I think, as we've talked at a high level in the food segment, we’ve kind of always talked 80% - 85% of that is the collagen business and I think that's pretty standard going forward. We're seeing a pretty nice improvement in the margin structure within the collagen business driven by a couple things and you have to fundamentally step back and look at the world and how the collagen trade flows happen around the world and really at the end of the day, China is an autonomous island or geography and so we self produce there and sell 99.9% domestic there. We had some volatility and margins there because of pigskin supply, high supply over the last couple of years. We have been able to widen out those margins again with better raw material pricing and also we have, I think, the best product as a western supplier in there from a food safety perspective and we are being recognized for that. Now you come to the other three continents of South America, Europe and the U.S. and as we describe to people, South America predominantly runs on animals hides and they recover and capture collagen out of the hide business. Slaughters have been strong down there. Hides pricing and availability has been favorable and the industry has probably 20%-25% too much capacity in South America from a gelatin business, different than a collagen peptide, but the gelatin business. As we brought up our Peptan or collagen peptide business in hydrolyzed collagen in South America today, it has diverted commodity gelatin to the new product and has helped those margins improve and once those margins in that core business improve it dominates and spills over into Europe and the U.S. And so, as we look forward, Q1 was pretty much hitting on all cylinders. Q2 little softer, but we look at a new run rate in the food segment driven by the improved margins in both the gelatin and collagen business and in Q1, Q2 of next year we are going to bring on two more plants and you will begin to see the impact there. So I think over, as we have always said that the food segment had run in that 130-140 EBITDA level pretty consistently over the last three or four years, I think you could see over the next couple of years anywhere from 25% to 40% improvement in that segment going forward driven by the new demand for the Peptan product line from us.

That's very helpful. Thank you so much.

This concludes our question-and-answer session. I would like to turn the conference back over to Randall C. Stuewe, Chairman and Chief Executive Officer for any closing remarks.

Thanks Andrew. Appreciate everybody's questions today, stay tuned. We will talk to you again here in November. Thank you.

The conference has now concluded. Thank you for attending today's presentation. You may now disconnect.